ERBB2 and Hypertension: Our baseline data reveal that patients with metastatic breast cancer tend to be older, less educated, less likely to have insurance, more frequently reside in rural areas, are more likely to be postmenopausal, and have a higher prevalence of hypertension and HR+/HER2- subtype.